CAPUCCI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 5.537
EU - Europa 3.138
AS - Asia 1.112
AF - Africa 213
SA - Sud America 199
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 6
Totale 10.217
Nazione #
US - Stati Uniti d'America 5.523
UA - Ucraina 658
RU - Federazione Russa 416
IT - Italia 414
IE - Irlanda 397
SG - Singapore 365
DE - Germania 339
SE - Svezia 287
DK - Danimarca 220
CN - Cina 207
BR - Brasile 185
HK - Hong Kong 182
TR - Turchia 174
MA - Marocco 133
FI - Finlandia 125
GB - Regno Unito 116
KR - Corea 116
FR - Francia 96
CI - Costa d'Avorio 72
IN - India 34
BE - Belgio 18
AT - Austria 14
EU - Europa 12
CA - Canada 10
NL - Olanda 9
CZ - Repubblica Ceca 8
RO - Romania 7
EC - Ecuador 6
PK - Pakistan 6
RS - Serbia 6
EG - Egitto 5
AU - Australia 4
ES - Italia 4
IQ - Iraq 4
AR - Argentina 3
JP - Giappone 3
NP - Nepal 3
DO - Repubblica Dominicana 2
JO - Giordania 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CL - Cile 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MX - Messico 1
OM - Oman 1
PE - Perù 1
PL - Polonia 1
PY - Paraguay 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 10.217
Città #
Jacksonville 707
Chandler 664
Fairfield 556
Dublin 394
Boardman 370
Ashburn 335
New York 248
Wilmington 239
Woodbridge 212
Seattle 207
Houston 192
Cambridge 182
Hong Kong 178
Singapore 165
Lawrence 149
Princeton 149
San Mateo 144
Ann Arbor 115
Des Moines 83
San Diego 73
Abidjan 72
The Dalles 68
Moscow 66
Beijing 61
Turin 53
Ancona 39
Centro 39
London 38
Los Angeles 33
Pune 30
Norwalk 21
Washington 20
Brussels 17
Nuremberg 15
Helsinki 14
Porto 14
Shanghai 14
Guangzhou 13
Belo Horizonte 12
Frankfurt am Main 12
São Paulo 12
Dallas 11
Redmond 11
Cavallermaggiore 8
Macerata 8
Santa Clara 8
Vienna 8
Wuhan 8
Kilburn 7
Milan 7
Pesaro 7
Rio de Janeiro 7
Campinas 6
Chiswick 6
Jiaxing 6
Nanning 6
Olomouc 6
Acton 5
Belgrade 5
Cairo 5
Chicago 5
Florence 5
Las Vegas 5
Ottawa 5
Rome 5
Salvador 5
San Benedetto del Tronto 5
Auburn Hills 4
Munich 4
Orlando 4
Pellezzano 4
Saint Petersburg 4
Stockholm 4
Wuxi 4
Amsterdam 3
Brasília 3
Campo Grande 3
Civitanova Marche 3
Foggia 3
Guayaquil 3
Hounslow 3
Indaiatuba 3
Jinhua 3
Lahore 3
Le Perray-en-Yvelines 3
Maceió 3
Pelotas 3
Porto Sant'Elpidio 3
Recife 3
Ribeirão Preto 3
Southwark 3
Sydney 3
Tolentino 3
Wandsworth 3
Amman 2
Atlanta 2
Baghdad 2
Barcelona 2
Betim 2
Bhubaneswar 2
Totale 6.295
Nome #
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on a Tertiary-Level Electrophysiology Laboratory in Italy 139
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. 118
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 110
Assessment of the German and Italian Stress Cardiomyopathy Score for Risk Stratification for In-hospital Complications in Patients with Takotsubo Syndrome 106
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 101
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 96
Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies 95
Cardiac resynchronization therapy and electrical storm: results of the OBSERVational registry on long-term outcome of ICD patients (OBSERVO-ICD) 94
Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. 89
Reproducibility of internal atrial defibrillation threshold in paroxysmal and persistent atrial fibrillation. 89
New anthyarrhythmic drugs for atrial fibrillation 89
Procedural sedation for direct current cardioversion: a feasibility study between two management strategies in the emergency department 86
Takotsubo syndrome in the paediatric population: A case report and a systematic review 86
Atrial tachyarrhythmia recurrence temporal patterns in bradycardia patients implanted with antitachycardia pacemakers. 84
Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD) 83
Comorbidities frequency in takotsubo syndrome: An international collaborative systematic review including 1109 patients 81
'Patient choice' concept in AF ESC Guidelines: is the clinician giving up? 80
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 80
Incidence and Clinical Impact of Recurrent Takotsubo Syndrome: Results From the GEIST Registry 79
Tachycardiomyopathy in Patients without Underlying Structural Heart Disease 79
Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. 78
Hospitalization in ICD recipients. 78
Amiodarone and digitalis: An odd couple in a tachycardiomyopathic patient 78
Flecainide: Electrophysiological properties, clinical indications, and practical aspects 78
Temporal relationship between subclinical atrial fibrillation and embolic events 78
A New Electrocardiographic Marker of Sudden Death in Brugada Syndrome: The S-Wave in Lead I 77
An Unusual Left Atrial Mass in a Woman with Active Breast Cancer and Recent Cardiothoracic Surgery 77
Coronary Spasm and Inflammation: Can We Kill 2 Birds With 1 Stone? 77
Dronedarone: a real innovation or a mere second-best choice? How to find the way among guidelines, regulatory agencies and daily clinical practice 77
Clinically guided pacemaker choice and setting: pacemaker expert programming study 76
The role of EP-guided therapy in ventricular arrhythmias: beta-blockers, sotalol, and ICD's. 75
Community-based automated external defibrillator only resuscitation for out-of-hospital cardiac arrest patients 75
Cardioembolism and takotsubo syndrome: A case report 75
Atrial overdriving is beneficial in patients with atrial arrhythmias: first results of the PROVE Study. 74
Subclinical atrial fibrillation and the risk of stroke 74
Ranolazine for rhythm control in atrial fibrillation: A systematic review and meta-analysis 74
Sedation in cardiac arrhythmias management 74
IntErnationaL eLeCTRicAl storm registry (ELECTRA): Background, rationale, study design, and expected results 74
Left intraventricular myocardial deformation dyssynchrony identifies responders to cardiac resynchronization therapy in patients with heart failure. 74
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. 74
Transient QRS amplitude attenuation is associated with clinical recovery in patients with takotsubo cardiomyopathy 73
Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation 73
Prospective evaluation of the multisensor HeartLogic algorithm for heart failure monitoring 73
Antiarrhythmic drugs for atrial fibrillation. 73
Entirely Subcutaneous Implantable Defibrillator: Safest Option in a Young Girl With Ventricular Tachycardia and Ebstein Anomaly 73
Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. 72
The ECG in the differential diagnosis between takotsubo cardiomyopathy and acute coronary syndrome 72
Temporal trends and temperature-related incidence of electrical storm: The TEMPEST Study (Temperature-related incidence of electrical storm) 72
Dr. Guerra, et al reply 72
Letter by Ciliberti and Capucci regarding article, "medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease" 72
ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT). 71
Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. 71
Cardiac resynchronization therapy improves ejection fraction and cardiac remodelling regardless of patients' age 71
Indications for implantable cardioverter defibrillator (ICD) therapy. 70
A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. 70
Current Therapeutic Options for Heart Failure in Elderly Patients 70
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. 70
Cardiomyopathy induced by frequent premature ventricular complexes originating from the right ventricular outflow tract: left ventricular systolic function recovery after transcatheter ablation. 69
Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation. 68
Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey. 68
Capture of atrial fibrillation reduces the atrial defibrillation threshold. 68
Speckle tracking echocardiography in systemic sclerosis: how far have we arrived and where can we go 68
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 67
Influence of left atrial enlargement and body weight on the development of atrial fibrillation: retrospective study on 205 dogs. 67
Far-field R wave oversensing in dual chamber pacemakers designed for atrial arrhythmia management: effect of pacing site and lead tip to ring distance. 66
Dronedarone for prevention of atrial fibrillation: a dose-ranging study. 66
Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation 66
New insights into the initiation of atrial fibrillation: a detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features. 65
Is there an 'atherosclerotic continuum' from angina with unobstructed coronary arteries to MINOCA? 65
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry 64
ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe. 64
Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: a single-blind, randomized, controlled study. 64
Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study). 64
Atrial Fibrillation and Congestive Heart Failure: should we aim to control the heart's rate or its rhythm? 64
Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: The ALPHEE study 64
Prospective Study of Tricuspid Regurgitation Associated With Permanent Leads After Cardiac Rhythm Device Implantation 64
Effect of atrial pacing on ventricular rate during atrial fibrillation. A human study. 64
CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: A systematic review and meta-analysis 63
Is invasive coronary provocation testing cost-effective among MINOCA patients? 63
Predictors of poor clinical outcomes in patients with acute myocardial infarction and non-obstructed coronary arteries (MINOCA) 63
Memorizzazione a distanza dei contenuti teorici derivati dai corsi BLS e BLS-D 63
Global Longitudinal Strain as a Predictor of First and Subsequent Arrhythmic Events in Remotely Monitored ICD Patients With Structural Heart Disease 63
Improving Stroke Risk Stratification Using the CHADS2 and CHA2DS2-VASc Risk Scores in Patients With Paroxysmal Atrial Fibrillation by Continuous Arrhythmia Burden Monitoring. 62
Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment. 61
Cardiac regeneration by progenitor cells: what is it known as and what is it still to be known as? 61
Safety and tolerability of a cardiologist-only approach to sedation for electrical cardioversion in the Emergency Department: The INSTEAD pilot trial 61
To the Editor— Flecainide and propafenone: Good twins for premature ventricular contractions’ killing but not exactly superimposable 61
Reproducible efficacy of loading oral propafenone in restoring sinus rhythm in patients with paroxysmal atrial fibrillation. 60
Skeletal muscle training in chronic heart failure. 60
Intravenous vernakalant for the rapid conversion of recent onset atrial fibrillation: systematic review and meta-analysis 60
Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis 60
Sleep Disordered Breathing and Atrial Fibrillation 60
A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. 60
Rebuttal of critique of Progetto Vita survival data 60
[Early and mid-term results of the transapical aortic valve Symetis Acurate TA: a viable solution in high-risk patients with severe vascular disease] 60
Emerging pharmacotherapies for the treatment of atrial fibrillation 60
Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. 60
Reduced peripheral skeletal muscle mass and abnormal reflex physiology in chronic heart failure. 59
Feasibility of a cardiologist-only approach to sedation for electrical cardioversion of atrial fibrillation: A randomized, open-blinded, prospective study 59
Interactions between Atrial Fibrillation, Cardiovascular Risk Factors, and ApoE Genotype in Promoting Cognitive Decline in Patients with Alzheimer's Disease: A Prospective Cohort Study 59
Totale 7.312
Categoria #
all - tutte 68.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.259


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020226 0 0 0 0 0 0 0 0 0 0 28 198
2020/20212.132 146 236 295 28 224 148 233 141 197 184 208 92
2021/20221.106 89 287 33 25 28 48 73 68 66 71 121 197
2022/20232.113 175 223 146 168 161 281 7 106 469 46 254 77
2023/20241.346 254 48 97 186 233 297 18 36 12 24 15 126
2024/20251.846 191 330 104 18 74 61 128 94 579 167 100 0
Totale 10.441